Search

Your search keyword '"He, Qihua"' showing total 18 results
Start Over Author "He, Qihua" Publisher ame publishing company
18 results on '"He, Qihua"'

1. Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials

Author

Yang, Lexie Zidanyue, primary, He, Qihua, additional, Zhang, Jianrong, additional, Ganti, Apar Kishor, additional, Stinchcombe, Thomas E., additional, Pang, Herbert, additional, and Wang, Xiaofei, additional

Published
2022
Full Text
View/download PDF

2. Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations

Author

He, Qihua, primary, Liu, Jun, additional, Cai, Xiuyu, additional, He, Miao, additional, Li, Caichen, additional, Liang, Hengrui, additional, Cheng, Bo, additional, Xia, Xiaojun, additional, Guo, Minzhang, additional, Liang, Peng, additional, Zhong, Ran, additional, Li, Feng, additional, Yu, Ziwen, additional, Zhao, Yi, additional, Ou, Limin, additional, Xiong, Shan, additional, Li, Jianfu, additional, Zhang, Jianrong, additional, He, Jianxing, additional, and Liang, Wenhua, additional

Published
2021
Full Text
View/download PDF

3. Role of lymphatic endothelial cells in the tumor microenvironment—a narrative review of recent advances

Author

He, Miao, primary, He, Qihua, additional, Cai, Xiuyu, additional, Chen, Zisheng, additional, Lao, Shen, additional, Deng, Hongsheng, additional, Liu, Xiwen, additional, Zheng, Yongmei, additional, Liu, Xiaoyan, additional, Liu, Jun, additional, Xie, Zhanhong, additional, Yao, Maojin, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2021
Full Text
View/download PDF

4. Early extubation in operating room after single-lung transplantation: a single institutional experience

Author

Ai, Qing, primary, Deng, Hongsheng, additional, Huang, Danxia, additional, He, Qihua, additional, Peng, Guilin, additional, Lu, Weixiang, additional, Liang, Hengrui, additional, Zhong, Yunpeng, additional, Li, Jianfu, additional, Xiong, Shan, additional, Cheng, Bo, additional, Li, Caichen, additional, Zhao, Yi, additional, Xing, Tuo, additional, Li, Run, additional, Chen, Ying, additional, Liang, Wenhua, additional, Xu, Xin, additional, and He, Jianxing, additional

Published
2021
Full Text
View/download PDF

5. Global burden of lung cancer: implications from current evidence

Author

Zhang, Jianrong, primary, Li, Jianfu, additional, Xiong, Shan, additional, He, Qihua, additional, Bergin, Rebecca J., additional, Emery, Jon D., additional, IJzerman, Maarten J., additional, Fitzmaurice, Christina, additional, Wang, Xiaoyan, additional, Li, Caichen, additional, Zhu, Feng, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2021
Full Text
View/download PDF

7. The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures

Author

He, Qihua, primary, Xin, Peiling, additional, Zhang, Mingzhe, additional, Jiang, Si, additional, Zhang, Jianrong, additional, Zhong, Shengyi, additional, Liu, Yang, additional, Guo, Minzhang, additional, Chen, Xuewei, additional, Xia, Xiaojun, additional, Pan, Zhenkui, additional, Guo, Chenye, additional, Cai, Xiuyu, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2019
Full Text
View/download PDF

8. Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection

Author

Liu, Yang, primary, Shen, Jianfei, additional, Liu, Liping, additional, Shan, Lanlan, additional, He, Jiaxi, additional, He, Qihua, additional, Jiang, Long, additional, Guo, Minzhang, additional, Chen, Xuewei, additional, Pan, Hui, additional, Peng, Guilin, additional, Shi, Honghui, additional, Ou, Limin, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2018
Full Text
View/download PDF

10. Direct comparison of autofluorescence bronchoscopy (AFB) and the combination of autofluorescence bronchoscopy and white light bronchoscopy (AFB + WLB) for detecting airway cancerous and precancerous lesions: a systematic review and meta-analysis

Author

Zhang, Jianrong, primary, Wu, Jieyu, additional, Xu, Zhiheng, additional, Yang, Yujing, additional, Liao, Hua, additional, Liang, Ziyan, additional, Jiang, Long, additional, Li, Jingpei, additional, Guo, Minzhang, additional, Chen, Xuewei, additional, Zeng, Yuan, additional, He, Qihua, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2018
Full Text
View/download PDF

11. Evaluation bias in objective response rate and disease control rate between blinded independent central review and local assessment: a study-level pooled analysis of phase III randomized control trials in the past seven years

Author

Zhang, Jianrong, primary, Zhang, Yiyin, additional, Tang, Shiyan, additional, Liang, Hengrui, additional, Chen, Difei, additional, Jiang, Long, additional, He, Qihua, additional, Huang, Yu, additional, Wang, Xinyu, additional, Deng, Kexin, additional, Jiang, Shuhan, additional, Zhou, Jiaqing, additional, Xu, Jiaxuan, additional, Chen, Xuanzuo, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2017
Full Text
View/download PDF

12. Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma—a systematic literature review and pooled-data analysis

Author

Jiang, Long, Yin, Weiqiang, Peng, Guilin, Wang, Wei, Zhang, Jianrong, Liu, Yang, Zhong, Shengyi, He, Qihua, Liang, Wenhua, and He, Jianxing

Subjects
Original Article
Abstract

Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) have been brought up that substitute for bronchioloalveolar carcinoma (BAC), according to the new classification of lung adenocarcinoma. There has been increasing opinions that argues for the adjustment of lymph node disposition in patients with such early stage tumors. Therefore, we sought to overview the prognosis and status of lymph node involvement in AIS/MIA patients.PubMed, Springer and Ovid databases were searched for relevant studies. Data was extracted and results summarized to demonstrate the disposition of lymph nodes in AIS/MIA.Twenty-three studies consisting of 6,137 lung adenocarcinoma were included. AIS/MIA accounted for 821 of the total 6,137. All included patients received curative surgery. After a review of the summarized data we found that only one patient (with MIA) had N1 node metastasis, N2 disease was not found in any of the included patients. In concordance with this, studies that reported 5-year disease free survival (5-year DFS) have almost 100% rate.Our findings indicated that patients with AIS/MIA have good survival prognosis after surgical resection, and that recurrence and lymph node metastasis in these patients is rare. Therefore, we strongly encouraged further studies to determine the role of different lymph node disposition strategies.

Published
2015

13. Correlation between epidermal growth factor receptor mutations and nuclear expression of female hormone receptors in non-small cell lung cancer: a meta-analysis

Author

He, Qihua, Zhang, Mingzhe, Zhang, Jianrong, Chen, Ying, He, Jiaxi, Shen, Jianfei, Liu, Yang, Zhong, Shengyi, Jiang, Long, Yang, Chenglin, Zeng, Yuan, Guo, Minzhang, Chen, Xuewei, He, Jianxing, and Liang, Wenhua

Subjects
Original Article
Abstract

Compared with male, female non-small cell lung cancer (NSCLC) patients have better response when treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), suggesting a potential association between female hormones and EGFR mutation. However, the results provided by previous studies were inconclusive and controversial. We sought to examine the link between the expression of nuclear female hormone receptors and EGFR mutations in NSCLC.Electronic databases were used to search the relevant articles. The involved hormone receptors included estrogen receptor (ER) and progesterone receptor (PR). The primary endpoint was the occurrence of ER/PR expression and EGFR mutation in NSCLC patients.Five studies fulfilled the criteria and were included in our analysis. Patients with high ER-β expression had higher positive EGFR mutation than low ER-β patients (44.2% vs. 23.7%), and there was a significant difference between the two groups [odds radio (OR) 3.44, 95% confidence interval (CI): 2.40-4.93, Z=6.72, P0.001]. However, there is no significant correlation between EGFR mutations and ER-α (when included ER-α3, OR 1.20, 95% CI: 0.62-2.33, Z=0.55, P=0.58; and when included ER-α4, OR 1.18, 95% CI: 0.62-2.25, Z=0.51, P=0.61) or PR (OR 1.29, 95% CI: 0.40-4.10, Z=0.43, P=0.67). No significant publication bias was observed.High nuclear expression of ER-β, but not ER-α or PR is correlated with EGFR mutations in NSCLC. The underlying mechanism and potential translational relevance warrant further investigation.

Published
2015

14. White light, autofluorescence and narrow-band imaging bronchoscopy for diagnosing airway pre-cancerous and early cancer lesions: a systematic review and meta-analysis

Author

Zhang, Jianrong, primary, Wu, Jieyu, additional, Yang, Yujing, additional, Liao, Hua, additional, Xu, Zhiheng, additional, Hamblin, Lindsey Tristine, additional, Jiang, Long, additional, Depypere, Lieven, additional, Ang, Keng Leong, additional, He, Jiaxi, additional, Liang, Ziyan, additional, Huang, Jun, additional, Li, Jingpei, additional, He, Qihua, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2016
Full Text
View/download PDF

15. Predictive value of BRCA1 expression on the efficacy of chemotherapy based on anti-microtubule agents: a pooled analysis across different malignancies and agents

Author

He, Qihua, primary, Zhang, Mingzhe, additional, Zhang, Jianrong, additional, Zhong, Shengyi, additional, Liu, Yang, additional, Shen, Jianfei, additional, He, Jiaxi, additional, Jiang, Long, additional, Yang, Chenglin, additional, Zeng, Yuan, additional, Guo, Minzhang, additional, Chen, Xuewei, additional, He, Jianxing, additional, and Liang, Wenhua, additional

Published
2016
Full Text
View/download PDF

16. Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Author

Jiang L, Yin W, Peng G, Wang W, Zhang J, Liu Y, Zhong S, He Q, Liang W, and He J

Abstract

Background: Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) have been brought up that substitute for bronchioloalveolar carcinoma (BAC), according to the new classification of lung adenocarcinoma. There has been increasing opinions that argues for the adjustment of lymph node disposition in patients with such early stage tumors. Therefore, we sought to overview the prognosis and status of lymph node involvement in AIS/MIA patients., Methods: PubMed, Springer and Ovid databases were searched for relevant studies. Data was extracted and results summarized to demonstrate the disposition of lymph nodes in AIS/MIA., Results: Twenty-three studies consisting of 6,137 lung adenocarcinoma were included. AIS/MIA accounted for 821 of the total 6,137. All included patients received curative surgery. After a review of the summarized data we found that only one patient (with MIA) had N1 node metastasis, N2 disease was not found in any of the included patients. In concordance with this, studies that reported 5-year disease free survival (5-year DFS) have almost 100% rate., Conclusions: Our findings indicated that patients with AIS/MIA have good survival prognosis after surgical resection, and that recurrence and lymph node metastasis in these patients is rare. Therefore, we strongly encouraged further studies to determine the role of different lymph node disposition strategies.

Published
2015
Full Text
View/download PDF

17. Correlation between epidermal growth factor receptor mutations and nuclear expression of female hormone receptors in non-small cell lung cancer: a meta-analysis.

Author

He Q, Zhang M, Zhang J, Chen Y, He J, Shen J, Liu Y, Zhong S, Jiang L, Yang C, Zeng Y, Guo M, Chen X, He J, and Liang W

Abstract

Background: Compared with male, female non-small cell lung cancer (NSCLC) patients have better response when treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), suggesting a potential association between female hormones and EGFR mutation. However, the results provided by previous studies were inconclusive and controversial. We sought to examine the link between the expression of nuclear female hormone receptors and EGFR mutations in NSCLC., Methods: Electronic databases were used to search the relevant articles. The involved hormone receptors included estrogen receptor (ER) and progesterone receptor (PR). The primary endpoint was the occurrence of ER/PR expression and EGFR mutation in NSCLC patients., Results: Five studies fulfilled the criteria and were included in our analysis. Patients with high ER-β expression had higher positive EGFR mutation than low ER-β patients (44.2% vs. 23.7%), and there was a significant difference between the two groups [odds radio (OR) 3.44, 95% confidence interval (CI): 2.40-4.93, Z=6.72, P<0.001]. However, there is no significant correlation between EGFR mutations and ER-α (when included ER-α3, OR 1.20, 95% CI: 0.62-2.33, Z=0.55, P=0.58; and when included ER-α4, OR 1.18, 95% CI: 0.62-2.25, Z=0.51, P=0.61) or PR (OR 1.29, 95% CI: 0.40-4.10, Z=0.43, P=0.67). No significant publication bias was observed., Conclusions: High nuclear expression of ER-β, but not ER-α or PR is correlated with EGFR mutations in NSCLC. The underlying mechanism and potential translational relevance warrant further investigation.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results